Srivastava Akhil, Filant Justyna, Moxley Katherine M, Sood Anil, McMeekin Scott, Ramesh Rajagopal
Department of Pathology, The Biomedical Research Center, Suite 1403, University of Oklahoma Health Sciences Center, 975 N.E., 10th Street, Oklahoma City, OK 73104, USA.
Curr Gene Ther. 2015;15(2):182-92. doi: 10.2174/1566523214666141224100612.
Exosomes are 30-100 nm bodies secreted from almost all types of cells into the extracellular spaces. They enclose in their lumen active genetic information in the form of messenger RNA (mRNA), micro RNA (miRNA), DNA and active peptides that are representative of the parental cell and can be isolated from different body fluids. Exosomes can participate in inter-cellular communication by trafficking molecules to their target cells. Because they can stably carry cargo including miRNA, mRNA, and proteins and can pass through stringent biological barriers (e.g., blood brain barrier) without eliciting an immune response, they are considered as an ideal acellular vehicle for drug delivery. In this review, we describe the structure and biogenesis of exosomes and new directions related to their role in diagnosis and treatment of diseases, especially for cancer. We also discuss potential challenges associated with exosomes that should be addressed before exosome-based therapy can be applied to clinical settings.
外泌体是几乎所有类型的细胞分泌到细胞外空间的30-100纳米小体。它们在其腔内包裹着以信使核糖核酸(mRNA)、微小核糖核酸(miRNA)、DNA和活性肽形式存在的活性遗传信息,这些代表了亲代细胞,并且可以从不同体液中分离出来。外泌体可以通过将分子运输到靶细胞来参与细胞间通讯。由于它们能够稳定携带包括miRNA、mRNA和蛋白质在内的货物,并且能够穿过严格的生物屏障(如血脑屏障)而不引发免疫反应,因此它们被认为是一种理想的无细胞药物递送载体。在本综述中,我们描述了外泌体的结构和生物发生,以及与其在疾病(尤其是癌症)诊断和治疗中的作用相关的新方向。我们还讨论了在外泌体疗法应用于临床之前应解决的与外泌体相关的潜在挑战。